This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Ann-Kristin Jenssen: Innovator in Neurodegenerative Disease Treatment
Introduction
Ann-Kristin Jenssen is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative research and patent work. Her dedication to improving treatment options for conditions like Friedreich's ataxia showcases her commitment to advancing medical science.
Latest Patents
Ann-Kristin Jenssen holds a patent for the treatment of Friedreich's ataxia using histone deacetylase inhibitors. This invention provides methods for treating Friedreich's ataxia and other neurodegenerative or neuromuscular conditions, highlighting her role in developing effective therapeutic strategies.
Career Highlights
Throughout her career, Jenssen has been associated with The Scripps Research Institute, where she has engaged in groundbreaking research. Her work has not only contributed to her own professional growth but has also had a lasting impact on the scientific community.
Collaborations
Ann-Kristin Jenssen has collaborated with notable colleagues, including Joel M Gottesfeld and David M Herman. These partnerships have further enriched her research and expanded the scope of her innovative work.
Conclusion
Ann-Kristin Jenssen's contributions to the treatment of neurodegenerative diseases through her patent work exemplify her dedication to medical innovation. Her research continues to inspire advancements in the field, making a significant difference in the lives of those affected by such conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile